COMMUNIQUÉS West-GlobeNewswire

First Patient Enrolled and Dosed in Novan’s SB206 Phase 3 Molluscum Program
04/06/2019
Phase 3 pivotal program commences and underway Investigative sites now activated and enrollment activities actioned Anticipated patient demand managed with a highly disciplined approach to trial execution Top line [...]
Amarin to Present at the Goldman Sachs 40th Annual Global Healthcare Conference
04/06/2019
BEDMINSTER, N.J. and DUBLIN, Ireland, June 04, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Athersys to Present at Jefferies 2019 Healthcare Conference
04/06/2019
Conference being held June 4-7, 2019 in New York City CLEVELAND, June 04, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today that Dr. Gil Van Bokkelen, Chairman and CEO, will present at the Jefferies [...]
Transactions in relation to share buyback program
04/06/2019
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 1, 2019, in accordance with article 5 of Regulation (EU) no. 596/2014 of April 16, 2014 on [...]
Coloplast announcement no. 05/2019 - Comment on market rumours
04/06/2019
Announcement no. 5/2019 Comment on market rumours Coloplast confirms that the company is conducting an unconditional strategic review of its Interventional Urology division. Further information will be communicated to [...]
Esperite NV (ESP) introduces Jouvene - Swiss Medicine Quintessence, the first combined offer of Stem Cell long term storage and highly accurate Whole Genome Sequencing for Consumer distribution.
04/06/2019
Amsterdam, The Netherlands – 04 June 2019 Jouvene’s new innovative offer will empower people with disease prevention, detection, diagnosis, treatment and management. With more than 10,000 diseases and medical conditions [...]
Cocoon Medical Appoints Miguel Pardos as Chief Executive Officer
04/06/2019
Barcelona, Spain, May. 27, 2019 – Cocoon Medical (“Cocoon”), a leading developer and provider of energy-based aesthetic systems for practitioners worldwide, today announced the appointment of Miguel Pardos as its Chief [...]
Esperite NV (ESP) introduces Jouvene - Swiss Medicine Quintessence, the first combined offer of Stem Cell long term storage and highly accurate Whle Genome Sequencing for Consumer distribution.
04/06/2019
Amsterdam, The Netherlands – 04 June 2019 Jouvene’s new innovative offer will empower people with disease prevention, detection, diagnosis, treatment and management. With more than 10,000 diseases and medical conditions [...]
Information on total number of voting rights and shares composing the share capital as at May 31st, 2019
04/06/2019
Paris, June 3 rd , 2019 – 6.00PM CET - Pixium Vision (FR0011950641 - PIX), a bioelectronic company developing innovative bionic vision systems to allow patients who have lost their sight to lead more independent lives, [...]
Information relative au nombre total de droits de vote et d’actions composant le capital social au 31 mai 2019
04/06/2019
Paris, le 3 juin 2019 – 18 :00 CET - Pixium Vision (FR0011950641 - PIX), société bioélectronique qui développe des systèmes de vision bionique innovants pour permettre aux patients ayant perdu la vue, de vivre de façon [...]
New Data on Curetis’ Unyvero LRT Panel for Pneumonia to be Presented at ASM Microbe 2019
04/06/2019
- Several scientific conference contributions outline benefits of U.S. FDA-cleared Unyvero LRT Application Cartridge in both endotracheal aspirate and bronchoalveolar lavage samples - Study shows that Unyvero LRT has [...]
NANOBIOTIX APPOINTS NEW CHIEF MEDICAL OFFICER AS THE COMPANY EVOLVES AFTER ACHIEVEMENT OF EUROPEAN MARKET APPROVAL
04/06/2019
NANOBIOTIX APPOINTS NEW CHIEF MEDICAL OFFICER AS THE COMPANY EVOLVES AFTER ACHIEVEMENT OF EUROPEAN MARKET APPROVAL Biopharmaceutical veteran Edwina Baskin-Bey, M.D., joins Nanobiotix as its new Chief Medical Officer ( [...]
Nanobiotix nomme un nouveau directeur médical à la suite de son autorisation de mise sur le marché européen
04/06/2019
NANOBIOTIX NOMME UN NOUVEAU DIRECTEUR M É DICAL À LA SUITE DE SON AUTORISATION DE MISE SUR LE MARCH É EUROP É EN Experte de l’industrie Biopharmaceutique, le Dr. Edwina Baskin-Bey rejoint Nanobiotix en tant que nouveau [...]
OV’s method can predict if neoadjuvant treatment with doxorubicin in breast cancer will be successful, data published in ASCO journal
04/06/2019
Investor News Hoersholm, Denmark and Cambridge, MA, US, June 4, 2019. – Oncology Venture A/S (“OV” or “the Company”) today announced that an e-abstract has been published in Journal of Clinical Oncology – an ASCO [...]
Verona Pharma Initiates Phase 2 Clinical Trial with Metered Dose Inhaler Formulation of Ensifentrine for Maintenance Treatment of COPD
04/06/2019
Ensifentrine delivery via MDI inhalers could dramatically expand clinical utility and commercial opportunity LONDON, June 04, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a [...]
ObsEva SA Announces Completion of Patient Recruitment in IMPLANT 4 Phase 3 Clinical Trial of Nolasiban for Improving IVF Outcomes
04/06/2019
Geneva, Switzerland and Boston, MA – June 4, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Sequana Medical Announces Unconditional IDE Approval from U.S. FDA to Start alfapump® Pivotal Study (POSEIDON)
04/06/2019
alfa pump pivotal study for treatment of recurrent or refractory ascites due to liver cirrhosis Optimised clinical trial design of up to 50 patients implanted with alfa pump in study cohort and shorter follow-up time [...]
MedMira Announces AGM Results
04/06/2019
HALIFAX, Nova Scotia, June 03, 2019 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR) held its 2019 Annual General Meeting of Shareholders on May 31, 2019 in Halifax, Nova Scotia. Incumbent Director Mr. Hermes Chan [...]
Veloxis Increases Share Capital in Connection with Exercise of Warrants
03/06/2019
Company Release no. 10/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 03 June 2019 Veloxis Increases Share Capital in Connection with Exercise of Warrants Veloxis Pharmaceuticals A/S announces that the Company's [...]

Pages